Lakibol, Yasmin P.

HRN: 21-41-88  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/03/2022
06/09/2022
IV DRIP
200mg
Q6
Pcap C
Waiting Final Action 
06/03/2022
AMPICILLIN 1GM (VIAL)
06/03/2022
06/09/2022
IV DRIP
780mg
Q8
Pcap C

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: